Vibhavadi Medical Center PCL (BKK:VIBHA)
Thailand · Delayed Price · Currency is THB 1.360
0.00 (0.00%)
Jun 12, 2026, 4:36 PM ICT
BKK:VIBHA Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 5,549 | 5,617 | 5,808 | 8,173 | 8,612 | 7,373 |
Other Revenue | 107.92 | 109.63 | 98.44 | 144.67 | 154.33 | 107.69 |
| 5,657 | 5,726 | 5,906 | 8,318 | 8,767 | 7,481 | |
Revenue Growth (YoY) | 9.50% | -3.04% | -29.00% | -5.12% | 17.18% | 21.68% |
Cost of Revenue | 4,033 | 4,044 | 4,088 | 5,834 | 5,876 | 5,179 |
Gross Profit | 1,624 | 1,682 | 1,818 | 2,484 | 2,891 | 2,302 |
Selling, General & Admin | 941.85 | 927.69 | 970.34 | 1,187 | 1,089 | 934.88 |
Operating Expenses | 941.85 | 927.69 | 970.34 | 1,187 | 1,089 | 934.88 |
Operating Income | 681.8 | 754.61 | 847.4 | 1,298 | 1,801 | 1,367 |
Interest Expense | -263.66 | -282.84 | -300.46 | -306.34 | -244.81 | -206.04 |
Interest & Investment Income | 272.56 | 268.84 | 248.16 | 360.27 | 375.97 | 342.43 |
Earnings From Equity Investments | 174.37 | 144.57 | 55.33 | 73.74 | 135.71 | 721.69 |
EBT Excluding Unusual Items | 865.08 | 885.18 | 850.44 | 1,425 | 2,068 | 2,225 |
Gain (Loss) on Sale of Investments | -128.53 | -324.14 | -214.93 | -153.87 | -100.23 | -11.23 |
Gain (Loss) on Sale of Assets | 1,313 | 1,313 | -0.41 | - | -14.91 | - |
Pretax Income | 2,160 | 1,985 | 635.09 | 1,271 | 1,953 | 2,214 |
Income Tax Expense | 93.63 | 62.05 | 89.56 | 196.84 | 302.02 | 224.39 |
Earnings From Continuing Operations | 2,067 | 1,923 | 545.53 | 1,075 | 1,651 | 1,989 |
Earnings From Discontinued Operations | -175.12 | -100.43 | 172.51 | - | -35.89 | -38.36 |
Net Income to Company | 1,892 | 1,822 | 718.04 | 1,075 | 1,615 | 1,951 |
Minority Interest in Earnings | -127.58 | -127.58 | -19.44 | -209.38 | -275.49 | -146.06 |
Net Income | 1,764 | 1,695 | 698.61 | 865.12 | 1,340 | 1,805 |
Net Income to Common | 1,764 | 1,695 | 698.61 | 865.12 | 1,340 | 1,805 |
Net Income Growth | 262.70% | 142.61% | -19.25% | -35.43% | -25.78% | 287.79% |
Shares Outstanding (Basic) | 13,485 | 13,485 | 13,523 | 13,576 | 13,576 | 13,576 |
Shares Outstanding (Diluted) | 13,485 | 13,485 | 13,523 | 13,576 | 13,576 | 14,887 |
Shares Change (YoY) | -0.12% | -0.28% | -0.39% | - | -8.81% | 0.71% |
EPS (Basic) | 0.13 | 0.13 | 0.05 | 0.06 | 0.10 | 0.13 |
EPS (Diluted) | 0.13 | 0.13 | 0.05 | 0.06 | 0.10 | 0.12 |
EPS Growth | 263.13% | 143.29% | -18.93% | -35.43% | -18.59% | 284.85% |
Free Cash Flow | 588.75 | 719.63 | 1,202 | 1,312 | 1,545 | 714.83 |
Free Cash Flow Per Share | 0.04 | 0.05 | 0.09 | 0.10 | 0.11 | 0.05 |
Dividend Per Share | 0.060 | 0.060 | 0.050 | 0.050 | 0.055 | 0.050 |
Dividend Growth | 20.00% | 20.00% | - | -9.09% | 10.00% | 25.00% |
Gross Margin | 28.70% | 29.38% | 30.78% | 29.86% | 32.97% | 30.77% |
Operating Margin | 12.05% | 13.18% | 14.35% | 15.60% | 20.55% | 18.27% |
Profit Margin | 31.19% | 29.60% | 11.83% | 10.40% | 15.28% | 24.13% |
Free Cash Flow Margin | 10.41% | 12.57% | 20.35% | 15.78% | 17.62% | 9.55% |
EBITDA | 1,231 | 1,352 | 1,469 | 1,932 | 2,410 | 1,837 |
EBITDA Margin | 21.76% | 23.61% | 24.87% | 23.22% | 27.49% | 24.56% |
D&A For EBITDA | 548.95 | 597.39 | 621.57 | 634.01 | 608.32 | 470.09 |
EBIT | 681.8 | 754.61 | 847.4 | 1,298 | 1,801 | 1,367 |
EBIT Margin | 12.05% | 13.18% | 14.35% | 15.60% | 20.55% | 18.27% |
Effective Tax Rate | 4.33% | 3.13% | 14.10% | 15.48% | 15.46% | 10.14% |
Revenue as Reported | 6,040 | 6,106 | 6,154 | 8,678 | 9,065 | 7,845 |